Metformin Hydrochloride: Medgend

ACTOPLUS MET [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Pioglitazone Hydrochloride^{C₁₉H₂₀N₂O₃SClH}]

RX

-

500mg : eq 15mg base (oral tablet)

850mg : eq 15mg base (oral tablet)

Takeda Pharms Usa^{Aug 29, 2005}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ACTOPLUS MET XR [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Pioglitazone Hydrochloride^{C₁₉H₂₀N₂O₃SClH}]

RX

-

1gm : eq 15mg base (oral tablet, extended release)

1gm : eq 30mg base (oral tablet, extended release)

Takeda Pharms Usa^{May 12, 2009}

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with pioglitazone and metformin or who have inadequate glycemic control on pioglitazone or metformin alone.
Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are already treated with a pioglitazone and metformin.
To reduce gastrointestinal side effects administer with a meal; as starting dose administer once daily with evening meal.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

FORTAMET [Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

1gm (oral tablet, extended release)

500mg (oral tablet, extended release)

Andrx Labs Llc^{Apr 27, 2004}

Method of lowering blood glucose by once daily administration.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GLIPIZIDE AND METFORMIN HYDROCHLORIDE [Glipizide^{C₂₁H₂₇N₅O₄S} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

2.5mg : 250mg (oral tablet)

2.5mg : 500mg (oral tablet)

Epic Pharma Llc^{Oct 27, 2005}
Heritage Pharms Inc^{Jun 23, 2010}
Mylan^{Apr 12, 2007}
Sun Pharm Inds Inc^{Jan 11, 2008}
Teva Pharms^{Oct 28, 2005}
Zydus Pharms Usa Inc^{Jan 31, 2011}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GLUCOPHAGE [Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

1gm (oral tablet)

500mg (oral tablet)

850mg (oral tablet)

Bristol Myers Squibb^{Nov 5, 1998}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GLUCOPHAGE XR [Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

500mg (oral tablet, extended release)

750mg (oral tablet, extended release)

Bristol Myers Squibb^{Oct 13, 2000}

Method of treating patient with type 2 diabetes by once daily administration.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GLUCOVANCE [Glyburide^{C₂₃H₂₈ClN₃O₅S} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

2.5mg : 500mg (oral tablet)

Bristol Myers Squibb^{Jul 31, 2000}

Treatment of type 2 diabetes.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GLUMETZA [Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

1gm (oral tablet, extended release)

500mg (oral tablet, extended release)

Santarus Inc^{Jun 3, 2005}

Indication of type ii diabetes.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

GLYBURIDE AND METFORMIN HYDROCHLORIDE [Glyburide^{C₂₃H₂₈ClN₃O₅S} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

1.25mg : 250mg (oral tablet)

2.5mg : 500mg (oral tablet)

Actavis Elizabeth^{Jun 28, 2005}
Aurobindo Pharma^{Nov 14, 2007}
Heritage Pharms Inc^{Jun 3, 2009}
Impax Labs Inc^{Feb 18, 2004}
Zydus Pharms Usa Inc^{Feb 29, 2016}

efficacy
1.0 (1)

side effects
0.0 (0)

danger
0.0 (0)

INVOKAMET [Canagliflozin^{2C₂₄H₂₅FO₅SH₂O} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

150mg : 1gm (oral tablet)

150mg : 500mg (oral tablet)

Janssen Pharms^{Aug 8, 2014}

Treatment of type 2 diabetes mellitus.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

INVOKAMET XR [Canagliflozin^{2C₂₄H₂₅FO₅SH₂O} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

150mg : 1gm (oral tablet, extended release)

150mg : 500mg (oral tablet, extended release)

Janssen Pharms^{Sep 20, 2016}

Treatment of type 2 diabetes mellitus.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

JANUMET [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Sitagliptin Phosphate^{C₁₆H₁₅F₆N₅OH₂OH₃O₄P}]

RX

-

1gm : eq 50mg base (oral tablet)

500mg : eq 50mg base (oral tablet)

Merck Sharp Dohme^{Mar 30, 2007}

Improvement of glycemic control in adults with type 2 diabetes mellitus.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with insulin.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with metformin and a ppar-gamma agonist.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

JANUMET XR [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Sitagliptin Phosphate^{C₁₆H₁₅F₆N₅OH₂OH₃O₄P}]

RX

-

1gm : eq 100mg base (oral tablet, extended release)

1gm : eq 50mg base (oral tablet, extended release)

500mg : eq 50mg base (oral tablet, extended release)

Merck Sharp Dohme^{Feb 2, 2012}

Improvement of glycemic control in adults with type 2 diabetes mellitus.
Method of treating type 2 diabetes mellitus in patients for whom treatment with both sitagliptin and metformin hcl extended release is appropriate.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

JENTADUETO [Linagliptin^{C₂₅H₂₈N₈O₂} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

2.5mg : 1gm (oral tablet)

2.5mg : 500mg (oral tablet)

2.5mg : 850mg (oral tablet)

Boehringer Ingelheim^{Jan 30, 2012}

Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-4 inhibitor in combination with metformin.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and/or a sulfonylurea.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
Method of treating type 2 diabetes mellitus by administering linagliptin in combination with metformin.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

JENTADUETO XR [Linagliptin^{C₂₅H₂₈N₈O₂} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

2.5mg : 1gm (oral tablet, extended release)

Boehringer Ingelheim^{May 27, 2016}

Method of treating type 2 diabetes in patients who have not been previously treated with an antihyperglycemic agent by administering linagliptin in combination with metformin.
Method of treating type 2 diabetes in patients with insufficient glycemic control despite therapy with one or more conventional antihyperglycemic agents by administering linagliptin in combination with metformin.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and, optionally, a sulfonylurea.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin.
Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
Method of treating type 2 diabetes mellitus by administering linagliptin in combination with metformin.
Method of treating type 2 diabetes.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

KAZANO [Alogliptin Benzoate^{C₁₈H₂₁N₅O₂C₇H₆O₂} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

eq 12.5mg base : 1gm (oral tablet)

eq 12.5mg base : 500mg (oral tablet)

Takeda Pharms Usa^{Jan 25, 2013}

Method of treating diabetes comprising administering a compound such as alogliptin.
Method of treating diabetes comprising administering alogliptin.
Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

KOMBIGLYZE XR [Metformin Hydrochloride^{C₄H₁₁N₅ClH} : Saxagliptin Hydrochloride^{C₁₈H₂₅N₃O₂ClH}]

RX

-

1gm : eq 2.5mg base (oral tablet, extended release)

1gm : eq 5mg base (oral tablet, extended release)

500mg : eq 5mg base (oral tablet, extended release)

Astrazeneca Ab^{Nov 5, 2010}

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin and metformin is appropriate.
Method for treating type ii diabetes mellitus by administering saxagliptin in combination with metformin.

efficacy
0.0 (0)

side effects
0.0 (0)

METFORMIN HYDROCHLORIDE [Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

RX

-

1gm (oral tablet, extended release)

500mg (oral tablet, extended release)

Actavis Labs Fl Inc^{Aug 1, 2016}
Alkem^{Nov 1, 2010}
Amneal Pharms Ny^{Jun 5, 2006}
Apotex^{Apr 23, 2002}
Atlas Pharms Llc^{Jan 24, 2002}
Aurobindo^{Jan 14, 2005}
Chartwell Life Sci^{Jan 24, 2002}
Cspc Ouyi Pharm Co^{Jul 11, 2016}
Dr Reddys Labs Inc^{Aug 23, 2006}
Glenmark Generics^{May 23, 2008}
Granules India^{Apr 22, 2010}
Indicus Pharma^{Nov 25, 2008}
Lupin Ltd^{Jul 19, 2013}
Marksans Pharma^{Mar 12, 2012}
Mylan^{Jan 24, 2002}
Mylan Pharms Inc^{Aug 1, 2012}
Provident Pharm^{Jul 28, 2006}
Sandoz^{Jan 25, 2002}
Sciegen Pharms Inc^{Sep 11, 2013}
Sun Pharm Inds^{Feb 21, 2002}
Sun Pharm Inds Inc^{Jan 29, 2002}
Sun Pharma Global^{Aug 1, 2016}
Teva^{Nov 5, 2002}
Torrent Pharms^{Jan 24, 2007}
Zydus Hlthcare^{Aug 28, 2014}
Zydus Pharms Usa^{Apr 18, 2005}
Aurobindo Pharma Ltd^{Jul 20, 2012}

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Metformin Hydrochloride FDA Approved Drugs